Signaling Pathways - IL Receptors - VEGFR3/FLT4 - P2X Receptors - Androgen Receptors
清除全部
- A8452 ODM-201中文名: 达洛鲁胺Target: Androgen ReceptorsSummary: 新一代雄激素受体抑制剂
- B5410 AZ 10606120 dihydrochlorideTarget: P2X ReceptorsSummary: P2X7受体拮抗剂
- B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂
- A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
- A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂
- A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体(Androgen receptor)拮抗剂
- A4429 Vialinin ATarget: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2Summary: USP/IsoT/UCH-L1 DUB抑制剂
- A3850 TAK-2427 Citation中文名: 瑞沙托维Target: Toll-like receptors (TLRs)|NO Donors / Precursors|IL ReceptorsSummary: TLR 4信号抑制剂
- A3136 A-740003Target: P2X ReceptorsSummary: P2X7受体拮抗剂
- A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂